Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)C2CC2)[C@@H](O)[C@H]1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?